SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer

Concurrent chemoradiotherapy is an effective treatment option for patients with low-grade colorectal cancer (CRC) in the local disease stage. At present, the principle of the Taiwan Medical Center is to treat CRC patients with combination radiotherapy and chemotherapy (high-dose 5-FU) for a period o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yueh-Jung, Huang, Siang-Ting, Chang, Ya-Hui, Lin, Shih-Yi, Lin, Weng-Ling, Chen, Ying-Jung, Chien, Shang-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605852/
https://www.ncbi.nlm.nih.gov/pubmed/37886949
http://dx.doi.org/10.3390/cimb45100506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605852/
https://www.ncbi.nlm.nih.gov/pubmed/37886949
http://dx.doi.org/10.3390/cimb45100506

Ejemplares similares